P. Geborek

5.9k total citations
72 papers, 4.4k citations indexed

About

P. Geborek is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, P. Geborek has authored 72 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 15 papers in Immunology and 12 papers in Hematology. Recurrent topics in P. Geborek's work include Rheumatoid Arthritis Research and Therapies (38 papers), Systemic Lupus Erythematosus Research (18 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). P. Geborek is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (38 papers), Systemic Lupus Erythematosus Research (18 papers) and Autoimmune and Inflammatory Disorders Research (12 papers). P. Geborek collaborates with scholars based in Sweden, United States and Denmark. P. Geborek's co-authors include Tore Saxne, Meliha C Kapetanovic, Ingemar F. Petersson, L. Jacobsson, Anders Gülfe, Jan Nilsson, Lars Erik Kristensen, Fredrik Bengtsson, L. E. Kristensen and Martin Englund and has published in prestigious journals such as The Lancet, Neuron and PLoS ONE.

In The Last Decade

P. Geborek

68 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Geborek Sweden	33	2.9k	1.3k	1.1k	543	494	72	4.4k
C. Birbara United States	23	3.8k 1.3×	1.9k 1.5×	1.8k 1.6×	531 1.0×	512 1.0×	43	5.5k
Bruce Freundlich United States	34	2.0k 0.7×	1.2k 0.9×	795 0.7×	364 0.7×	583 1.2×	54	3.8k
Malcolm Smith Australia	43	2.7k 0.9×	1.9k 1.4×	606 0.6×	231 0.4×	630 1.3×	161	6.1k
Giovanni Lapadula Italy	38	2.1k 0.7×	1.0k 0.8×	628 0.6×	236 0.4×	576 1.2×	191	4.5k
Pedro Machado United Kingdom	35	3.0k 1.0×	1.4k 1.1×	998 0.9×	259 0.5×	343 0.7×	240	4.9k
Marcello Govoni Italy	37	2.2k 0.7×	1.2k 0.9×	589 0.5×	149 0.3×	586 1.2×	227	4.2k
Daniel Baker United States	37	2.5k 0.8×	1.3k 1.0×	985 0.9×	267 0.5×	218 0.4×	72	5.2k
Philippe Goupille France	44	3.8k 1.3×	1.6k 1.3×	1.1k 1.0×	445 0.8×	1.7k 3.4×	215	7.2k
Francesco Trotta Italy	36	1.9k 0.6×	891 0.7×	516 0.5×	150 0.3×	523 1.1×	154	3.6k
Jürgen Rech Germany	43	3.7k 1.3×	2.5k 1.9×	1.2k 1.1×	768 1.4×	569 1.2×	187	7.0k

Countries citing papers authored by P. Geborek

Since Specialization

Citations

This map shows the geographic impact of P. Geborek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Geborek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Geborek more than expected).

Fields of papers citing papers by P. Geborek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Geborek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Geborek. The network helps show where P. Geborek may publish in the future.

Co-authorship network of co-authors of P. Geborek

This figure shows the co-authorship network connecting the top 25 collaborators of P. Geborek. A scholar is included among the top collaborators of P. Geborek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Geborek. P. Geborek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jörntell, Henrik, Fredrik Bengtsson, P. Geborek, et al.. (2014). Segregation of Tactile Input Features in Neurons of the Cuneate Nucleus. Neuron. 83(6). 1444–1452. 87 indexed citations

Kristensen, Lars Erik, Ingemar F. Petersson, P. Geborek, et al.. (2011). Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study. Lara D. Veeken. 51(2). 243–249. 38 indexed citations

Kapetanovic, Meliha C, Elisabet Lindqvist, P. Geborek, Tore Saxne, & Katharina Eberhard. (2011). Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s. Scandinavian Journal of Rheumatology. 40(6). 433–438. 27 indexed citations

Kristensen, L. E., J. Karlsson, Martin Englund, et al.. (2010). Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register. Arthritis Care & Research. 62(10). 1362–1369. 78 indexed citations

Neovius, Martin, Anders Sundström, L. Jacobsson, et al.. (2010). Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register. Annals of the Rheumatic Diseases. 70(3). 516–519. 52 indexed citations

Assen, Sander van, Nancy Agmon‐Levin, Ori Elkayam, et al.. (2010). EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Annals of the Rheumatic Diseases. 70(3). 414–422. 443 indexed citations

Kapetanovic, Meliha C, Elisabet Lindqvist, Magnus Simonsson, et al.. (2010). Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease. Scandinavian Journal of Rheumatology. 39(5). 353–359. 24 indexed citations

Vollenhoven, Ronald van, Sofia Ernestam, P. Geborek, et al.. (2009). Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. The Lancet. 374(9688). 459–466. 224 indexed citations

Kobelt, Gisela, Peter Lindgren, & P. Geborek. (2009). Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data. Scandinavian Journal of Rheumatology. 38(6). 409–418. 18 indexed citations

10.

Karlsson, J., Lars Erik Kristensen, Meliha C Kapetanovic, et al.. (2007). Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register. Lara D. Veeken. 47(4). 507–513. 123 indexed citations

11.

Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS).. Arthritis & Rheumatism. 54.

12.

Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS).. Arthritis & Rheumatism. 54. 1 indexed citations

13.

Jacobsson, L., Carl Turesson, Jan Nilsson, et al.. (2006). Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(5). 670–675. 163 indexed citations

14.

Kapetanovic, Meliha C, Tore Saxne, Jan Nilsson, & P. Geborek. (2006). Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Lara D. Veeken. 46(4). 608–611. 145 indexed citations

15.

Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 3 indexed citations

16.

Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 448–449. 2 indexed citations

17.

Feltelius, Nils, Michael Fored, Peter Blomqvist, et al.. (2004). Safety and efficacy of adalimumab in arthritis patients previously treated with another biologic agent. Annals of the Rheumatic Diseases. 63. 2 indexed citations

18.

Brandt, Lena, L Bertilsson, Nils Feltelius, et al.. (2004). A national database for co-morbidity in RA to evaluate drug safety. Solid cancers in RA and following anti-TNF treatment. Annals of the Rheumatic Diseases. 63.

19.

Askling, Johan, Lena Brandt, L Bertilsson, et al.. (2004). Risk for lymphomas following TNF-blockade. Comparisons with a nationwide co-morbidity database. Annals of the Rheumatic Diseases. 63. 1 indexed citations

20.

Geborek, P., et al.. (1990). Intraarticular corticosteroid injection into rheumatoid arthritis knees improves extensor muscles strength. Rheumatology International. 9(6). 265–270. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact